The following information is about Sirolimus.

Sirolimus Defined

Are you looking for additional Huntingtons Disease > Sirolimus news? Try our new "Sirolimus News Focus" area.

Off-site Sirolimus Links, User Submitted

The following links have been collected through user bookmark submission in the Sirolimus category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Thu Sep 25

• The mTOR pathway 2008
• Image:MTOR-pat hway-betz.jpg - Wikipedia, the free encyclopedia

Mon Mar 10

• Sirolimus - Yahoo! Health: What is sirolimus? Sirolimus lowers your body's immune system. The immune system helps your body fight infections...
• Sirolimus - Wikipedia, the free encyclopedia: Sirolimus is a relatively new immunosuppress ant drug used to prevent rejection in organ transplantatio n, and is especially useful in kidney transplants. Sirolimus is a macrolide. It is marketed under the trade name Rapamune by Wyeth.
• Rapamune Consumer Information: What are some possible side effects of Rapamune? (This is not a complete list of side effects reported with Rapamune. Your health care provider can discuss with you a more complete list of side effects.) Rapamune is an immunosuppress ant drug. Immunosu
• MedlinePlus Drug Information: Sirolimus: Sirolimus is used in combination with other medications to prevent rejection of kidney transplants. Sirolimus is in a class of medications called immunosuppress ants. It works by suppressing the body's immune system.
• Sirolimus (Oral Route) - MayoClinic.com: US Brand Names * Rapamune Description Sirolimus belongs to a group of medicines known as immunosuppress ive agents. It is used to lower the body's natural immunity in patients who receive kidney transplants.

Tue Sep 25

• Safety and Efficacy of Sirolimus- and Paclitaxel-Elu ting Coronary Stents || NEJM 2007: Stone GW, Moses JW, Leon MB, Colombo A, Schampaert E, Grube E, et al.
• C-SIRIUS | Canadian study of the sirolimus-elut ing stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS): Schampaert E, Cohen EA, Popma JJ, et al.
• Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Uns ettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) | A: Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Uns ettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) C

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Sirolimus. If you would like to find related tags we recommend Tag Patterns > Sirolimus

Off-site Sirolimus Research Links

If you still need additional information on Sirolimus then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.